Biostatistics/Data Management
Providing a forum for information and discussion about current and evolving issues in these disciplines as well as training on basic topics
Leadership
CO-CHAIRS
Jon Haddad, Synta Pharmaceuticals Corporation
Cindy Steinberg, BioBridges LLC
Steering Committee
Jennifer Angell, Associate Director, Biostatistics, Genzyme Corporation
Jameelah Aziz, Manager Clinical Data Management, Cubist Pharmaceuticals
Michelle Harrison, Manager, Clinical Data Management, Coley Pharmaceuticals Group
Kay Larholt, Vice President and Executive Director, Biometrics, Abt Associates
Scott Moseley, Director, Biometrics, Vertex Pharmaceuticals
Mission
Our Mission is to provide a sustainable non-commercial forum for information, discussion and the exchange of ideas about Biostatistics and Data Management (BDM) for the MBC membership. Topics will include current and evolving issues in these disciplines as well as address membership needs for training on basic topics. The BDM Committee will disseminate information through workshops and presentations by leveraging the direct experience of industry experts and the MBC membership.
Action Plan
The BDM Committee will utilize its steering committee to develop and organize an annual plan of meetings to be held each month. Topics and formats will be consistent with the BDM committee’s mission, continuing a tradition of promoting new ideas and finding new ways to look at Biostatistics and Data Management in the clinical trials process. In addition, we will participate in joint functions with other MBC committees to bring expertise from different perspectives of clinical development such as Technology and Regulatory Compliance as they relate to the overall success of managing a clinical trial.
The BDM Committee will develop a mechanism for succession planning and continuity, and will establish guidelines for steering committee participation.
Meetings
Past Presentations
« Back to committees list